StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Inari Medical by Quarter

Inari Medical (Standalone Pre-Acquisition through FY2024Q3) — Gross Margin (%) (%)

QuarterlyAnnual

Stryker Inari Medical: 87.1% in Q3 2024, down 1.4 pts from a year earlier. No newer figure appears in the documents we track.

Latest, Q3 2024
87.1%
Period ended Sep 30, 2024
Change on a year earlier
-1.4 pts
88.5% in Q3 2023
History
17 quarters
Since Q2 2020
Sources
13
Documents cited below

Where the Q3 2024 figure comes from

“Gross margin for the three months ended September 30, 2024 decreased to 87.1%, compared to 88.5% for the three months ended September 30, 2023, primarily due to product mix, the ramp up costs associated with new products, and increasing internationalization of the business.”

Reported in Inari Medical, Inc. (NARI) Form 10-K, Form 10-Q & Form 8-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInari Medical (Standalone Pre-Acquisition through FY2024Q3) — Gross Margin (%) (%)Year on yearSource
Q3 2024Sep 30, 202487.1%-1.4 ptsInari Medical Form 10-Q (0001531048-24-000060|nari-20240930.htm) ↗
Q2 2024Jun 30, 202486.3%-2.1 ptsInari Medical Form 10-Q (0001531048-24-000051|nari-20240630.htm) ↗
Q1 2024Mar 31, 202486.8%-1.4 ptsInari Medical Form 10-Q (0001531048-24-000035|nari-20240331.htm) ↗
Q4 2023Dec 31, 202387.1%-0.7 ptsInari Medical Form 8-K (0001531048-24-000022|nari-20240228xex991xpressr.htm) ↗
Q3 2023Sep 30, 202388.5%0.0 ptsInari Medical Form 10-Q (0001531048-24-000060|nari-20240930.htm) ↗
Q2 2023Jun 30, 202388.4%-0.4 ptsInari Medical Form 10-Q (0001531048-24-000051|nari-20240630.htm) ↗
Q1 2023Mar 31, 202388.2%-0.3 ptsInari Medical Form 10-Q (0001531048-24-000035|nari-20240331.htm) ↗
Q4 2022Dec 31, 202287.8%-2.3 ptsInari Medical Form 8-K (0000950170-23-004646|nari-ex99_1.htm) ↗
Q3 2022Sep 30, 202288.5%-1.8 ptsInari Medical Form 10-Q (0000950170-22-021242|nari-20220930.htm) ↗
Q2 2022Jun 30, 202288.8%-3.6 ptsInari Medical Form 10-Q (0001531048-23-000024|nari-20230630.htm) ↗
Q1 2022Mar 31, 202288.5%-3.4 ptsInari Medical Form 10-Q (0001531048-23-000009|nari-20230331.htm) ↗
Q4 2021Dec 31, 202190.1%–Inari Medical Form 8-K (0000950170-22-001774|nari-ex99_1.htm) ↗
Q3 2021Sep 30, 202190.3%-1.4 ptsInari Medical Form 10-Q (0000950170-22-021242|nari-20220930.htm) ↗
Q2 2021Jun 30, 202192.4%+6.1 ptsInari Medical Form 10-Q (0000950170-22-014261|nari-20220630.htm) ↗
Q1 2021Mar 31, 202191.9%–Inari Medical Form 10-Q (0000950170-22-007406|nari-20220331.htm) ↗
Q3 2020Sep 30, 202091.7%–Inari Medical Form 10-Q (0000950170-21-003752|nari-20210930.htm) ↗

Breakdown

What makes up inari Medical

Cite this data

StockData. (2026). Stryker Inari Medical (%), quarterly Q2 2020–Q3 2024 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/nari-gm-pct

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.